knowledge -WSS

knowledge

author：entertainment 2025-09-28 02:31:37 - browse：95935

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Listen: More tumult at BIO & coercive care for sickle cell patients

explore

WSS

5 ways to address the shortage of health care workers

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Color Health wants to make cancer screenings convenient

FDA poised to publish guidelines for clinical trial diversity

Readout Newsletter: Beam, Prozac, "TechBio" and more

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Wikipedia

knowledge

hotspot

In age of alternative facts, a scholarly course on calling out crap

H5N1 virus can be tracked in retail milk, scientists say

What does generative AI mean for health care? We asked experts

Elisabeth Bik tackles the widespread issue of research misconduct

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Continuity nursing helped my family in our darkest PICU moments

Liver decline slowed by off

ChatGPT in medicine: STAT answers readers' burning questions

Liver decline slowed by off

focus

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Are embryos people? Reproductive medicine's future depends on the answer

Cholera vaccine supplies dangerously low, outbreaks surging

For longer

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

explore

Wikipedia

focus

Wikipedia